SciClone Shells Out $2.5M To Investors Amid FCPA Probes
SciClone Pharmaceuticals Inc. said Wednesday that it had agreed to pay $2.5 million and make corporate governance changes to settle three consolidated shareholder derivative lawsuits accusing its officers and directors of...To view the full article, register now.
Already a subscriber? Click here to view full article